Pharmaceutical composition active against a viral infection of the coronavirus type

摘要

Pharmaceutical composition active against a viral infection of the coronavirus type The invention relates to a pharmaceutical composition comprising a pharmaceutical carrier and an amount of agent active against a viral infection of a human or animal body by a virus of the coronavirus type including SARS-CoV. , MERS-CoV and SARS-SoV-2 causing Covid-19 disease. The composition comprises a naphthylisoquinoline alkaloid or a mixture of naphthylisoquinoline alkaloids or their derivatives. The invention relates to a method of treating or preventing a viral infection comprising a step of administration by the oral route or by injection of such a pharmaceutical composition.